FDA Drug Safety Office Is “Separate, But Unequal,” Senate Committee Says

A Senate committee investigation into FDA's handling of pediatric suicidality concerns with antidepressant drugs is focusing on the "unequal" status of the Office of Drug Safety and the Office of New Drugs

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet